WallStreetZenWallStreetZen

NASDAQ: ABOS
Acumen Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Acumen Pharmaceuticals revenue was $0.00 for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ABOS annual revenue was $0.0, with N/A growth year-over-year.

ABOS revenue history

Current Revenue
$0.0
Current Earnings
-$81.7M
Current Profit Margin
0%

Be the first to know when ABOS announces revenue.

ABOS Revenue History By Year

ABOS Yearly RevenueABOS RevenueABOS ChangeABOS Revenue Growth
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Acumen Pharmaceuticals Revenue FAQ

What was ABOS's revenue last quarter?

On Invalid Date, Acumen Pharmaceuticals (NASDAQ: ABOS) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Acumen Pharmaceuticals's revenue was $0.00.

What was Acumen Pharmaceuticals's revenue in 2023?

Acumen Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.

How much does Acumen Pharmaceuticals make in a day?

Based on Acumen Pharmaceuticals annual revenue for the past four years, ABOS makes an average of $0.00 per day.

What was Acumen Pharmaceuticals's annual revenue growth in the past year?

As of Q1 2025, Acumen Pharmaceuticals's revenue has grown null year over year. Acumen Pharmaceuticals's revenue in the past year totaled $0.00.

How much does Acumen Pharmaceuticals make in a year?

Acumen Pharmaceuticals's revenue by year for the past four years is:
  • Acumen Pharmaceuticals's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
  • Acumen Pharmaceuticals's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
  • Acumen Pharmaceuticals's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Acumen Pharmaceuticals's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.